Health Care Services

AirSculpt Tech

AirSculpt Tech released FY2026 Q1 earnings on May 8 Pre-Market (EST), actual revenue USD 39.39 M (forecast USD 39.23 M), actual EPS USD -0.0345 (forecast USD -0.03)

AirSculpt Tech to Release FY2026 Q1 Earnings on May 8, Pre-Market EST; Forecast Revenue USD 39.23 M, EPS USD -0.03

AIRS Shareholder Chernett Jorey Makes a Significant Purchase

Jorey Chernett Increased Holdings in AirSculpt Shares

AirSculpt Revises 2025 Fiscal Year Non-GAAP Financial Metrics

AirSculpt reports FY25 net loss increase and revenue decline

AirSculpt Tech released FY2025 Q4 earnings on March 31 Pre-Market (EST), actual revenue USD 33.44 M (forecast USD 34.56 M), actual EPS USD 0.0209 (forecast USD -0.03)

AirSculpt Tech released FY2025 earnings on March 31 Pre-Market (EST), actual revenue USD 151.82 M (forecast USD 152.94 M), actual EPS USD -0.193 (forecast USD -0.24)

AirSculpt Tech to Release FY2025 Q4 Earnings on April 2, Pre-Market EST; Forecast Revenue USD 34.56 M, EPS USD -0.03

Major Shareholder Increases Stake in AirSculpt Technologies

Jorey Chernett Increases Stake in Airsculpt Technologies

Aaron Rollins Discloses Stake in Airsculpt Technologies and Considers Strategic Options

Chernett Jorey Increased Holdings in Airsculpt Technologies

AirSculpt Technologies Reports Missed Earnings, Shares Plunge

AirSculpt Tech released FY2025 Q3 earnings on November 7 Pre-Market EST, actual revenue USD 34.99 M (forecast USD 39.8 M), actual EPS USD -0.1523 (forecast USD -0.03)

AirSculpt Tech released FY2025 9 Months Earnings on November 7 Pre-Market EST, with actual revenue of USD 118.38 M and actual EPS of USD -0.2123

AirSculpt Technologies to Release Q3 2025 Earnings on November 7

AirSculpt Tech to release FY2025 Q3 earnings on November 7 Pre-Market EST, forecast revenue USD 39.8 M, EPS USD -0.03

AirSculpt Tech released FY2025 Q2 earnings on August 1 Pre-Market (EST), actual revenue USD 44.01 M (forecast USD 45.59 M), actual EPS USD -0.0099 (forecast USD -0.0066)

AirSculpt Tech released FY2025 Semi-Annual earnings on August 1 Pre-Market EST, actual revenue USD 83.38 M, actual EPS USD -0.06

Netcapital

PicoCELA

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

Agape ATP

Tradr 2X Long QBTS Daily ETF

Co-Diagnostics

Akanda

Tradr 2X Long RGTI Daily ETF

NewGenIvf

Defiance Daily Target 2X Long RGTI ETF

AIRS

AirSculpt Technologies (NASDAQ:AIRS) reports a return to same-store sales growth after two years of declines, driven by changes in marketing strategy. The company plans to expand services related to GLP-1 weight-loss drug side effects and aims to grow its clinic presence in the U.S. AirSculpt operates 31 centers and sees potential for 100 more locations. Financially, the company reduced debt to $46 million and ended Q1 2026 with $16.7 million in cash, with a net debt-to-EBITDA ratio below 2.5 times.

Market Beat

Apyx Medical

AirSculpt Technologies Sees Sales Rebound, GLP-1 Tailwind for Body Contouring Growth

AirSculpt Technologies (NASDAQ:AIRS) reported quarterly earnings of ($0.01) per share, surpassing estimates of ($0.02) by $0.01. Revenue reached $39.39 million, exceeding expectations of $39.20 million. The company noted a negative net margin of 7.68% and a negative return on equity of 5.01%. Management highlighted growth opportunities from GLP-1 drug adoption and plans for skin-tightening procedures. The company reaffirmed FY26 revenue guidance of $151M–$157M. Shares traded down 0.8% to $3.43, with hedge funds holding 91.54% of the stock. Analysts have a consensus price target of $6.00.

AirSculpt Technologies (NASDAQ:AIRS) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

AirSculpt Technologies (NASDAQ:AIRS) reported Q1 fiscal 2026 results, marking a "key turning point" with stabilized revenue and positive same-center sales for the first time in over two years. Revenue was $39.4 million, flat year-over-year, with gross margin expanding to 60%. CEO Yogi Jashnani highlighted improvements in marketing and sales execution, while CFO Michael Arthur noted a reduction in debt and cash flow from operations of $5 million. The company is exploring opportunities in the aesthetics market influenced by GLP-1 medications, although new procedures are not yet significant contributors. Full-year guidance for 2026 remains reaffirmed.

AirSculpt Technologies Q1 Earnings Call Highlights

Earnings Watch

AirSculpt Tech | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 39.39 M

AirSculpt Technologies, Inc. reported its first quarter fiscal 2026 results, showing a 1% increase in same center sales and reaffirming its full-year guidance of $151 to $157 million in revenue. The company achieved a case volume of 3,082, with revenue flat at $39.4 million and a reduced net loss of $2.4 million. CEO Yogi Jashnani expressed confidence in the company's growth strategy and financial stability, highlighting a strengthened balance sheet and positive momentum heading into the second quarter. A conference call is scheduled for May 8, 2026, to discuss the results further.

StockTitan

AirSculpt Technologies Reports First Quarter Fiscal 2026 Results | AIRS Stock News

AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for First Quarter Fiscal 2026 Results | AIRS Stock News

AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for First Quarter Fiscal 2026 Results | AIRS Stock News

AirSculpt Technologies major shareholder Jorey Chernett purchased 40,000 shares at $2.54 each, totaling $101,600, increasing his ownership by 0.57%. Following this transaction, he owns 7,053,761 shares valued at approximately $17.9 million. Chernett has made several recent purchases, including 20,000 shares at $2.60 and 60,000 shares at $2.93. The company's stock traded at $2.59, with a market cap of $182.37 million and a PE ratio of -13.66. AirSculpt reported a quarterly EPS of $0.02, exceeding estimates, but revenue declined 14.8% year-over-year.

AirSculpt Technologies (NASDAQ:AIRS) Major Shareholder Jorey Chernett Buys 40,000 Shares

AirSculpt Tech(AIRS.US)

AirSculpt Technologies Sees Sales Rebound, GLP-1 Tailwind for Body Contouring Growth

AirSculpt Technologies (NASDAQ:AIRS) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

AirSculpt Technologies Q1 Earnings Call Highlights

AirSculpt Tech | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 39.39 M

AirSculpt Technologies Reports First Quarter Fiscal 2026 Results | AIRS Stock News

AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for First Quarter Fiscal 2026 Results | AIRS Stock News

AirSculpt Technologies (NASDAQ:AIRS) Major Shareholder Jorey Chernett Buys 40,000 Shares